The gene-editing technology known as CRISPR has attracted much excitement and investor interest with its potential to someday treat diseases by fixing faulty copies of genes. But recently, a different approach called RNA editing, which could offer advantages over CRISPR, has been gaining ground in academic labs and start-ups, according to an article in Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society.
RNA editing uses an enzyme called ADAR to make precise edits to RNA, the shorter-lived cousin to DNA that acts as a blueprint for proteins. Researchers direct ADAR to specific RNAs with a guide sequence attached to the enzyme. Unlike CRISPR gene editing, the effects of RNA editing are reversible because cells are constantly making new copies of RNA. Therefore, RNA editing avoids the risks of permanent gene editing with CRISPR, writes Assistant Editor Ryan Cross, and could also be used to treat temporary conditions, such as pain or inflammation.
However, finding an easy way to control how ADAR makes its edits has been challenging. Researchers have tried chemically attaching ADAR to a guide RNA, adding an RNA-binding protein or even linking the catalytic portion of ADAR to the bacterial Cas9 enzyme used in CRISPR. However, these approaches require getting the modified enzymes into human cells. Some researchers are working on using human cells’ own ADAR for RNA editing, by introducing chemically modified guide RNAs that recruit the editing enzyme and direct it to specific RNAs. With researchers and investors becoming increasingly interested in this approach, RNA editing could someday give CRISPR a run for its money, Cross writes.
The article, “Watch out, CRISPR. The RNA editing race is on,” is freely available here.
Learn more: Interest in RNA editing heats up
The Latest on: RNA editing
[google_news title=”” keyword=”RNA editing” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: RNA editing
- First pig kidney has been transplanted into a living person, but we're still a long way from solving organ shortageson March 28, 2024 at 10:50 am
In a world first, we heard last week that US surgeons had transplanted a kidney from a gene-edited pig into a living human. News reports said the procedure was a breakthrough in ...
- Korro Bio Earns Buy Rating on Promising RNA Editing Technology for AATD Treatmenton March 28, 2024 at 3:26 am
Analyst Mitchell Kapoor of H.C. Wainwright maintained a Buy rating on Korro Bio (KRRO – Research Report), boosting the price target to ...
- Split Decision: Synthego Spins Out EditCo Bio Around Engineered Cell Platformon March 27, 2024 at 4:30 am
Synthego announced that it will focus solely on the therapeutic applications of CRISPR while spinning off a new company, EditCo Bio, which is positioned to deliver edited cells and highly optimized ...
- Korro Reports Full Year 2023 Financial Results and Highlights Recent Progresson March 26, 2024 at 1:26 pm
On track for regulatory filing for First-in-Human study of KRRO-110 in Alpha-1 Antitrypsin Deficiency (AATD) patients anticipated in the second ...
- Prestigious Blavatnik awards for young scientists in Israel announces 2024 laureateson March 26, 2024 at 5:55 am
The Blavatnik Family Foundation, the Israel Academy of Sciences and Humanities, and the New York Academy of Sciences announced on Tuesday the names of the three laureates,Blavatnik Awards scholars are ...
- Messenger RNAs with multiple 'tails' could lead to more effective therapeutics, say researcherson March 22, 2024 at 3:00 am
Messenger RNA (mRNA) made its big leap into the public limelight during the pandemic, thanks to its cornerstone role in several COVID-19 vaccines. But mRNAs, which are genetic sequences that instruct ...
- Meet the Brown researcher who wants to help sequence all potential RNA modificationson March 19, 2024 at 7:04 pm
Alfonzo, a world-renowned RNA biologist who came to Brown in 2023, aims to better understand RNA and its modifications. To do so, Alfonzo and his colleagues are working to lay the groundwork for ...
- 5th RNA Editing Summit 2024on February 11, 2024 at 3:59 pm
Scheduled for June 2024, the 5th RNA Editing Summit is set to spotlight brand-new advances towards the clinic and strategies for targeting beyond the liver. With an expert speaker faculty ...
- Kinetoplastids and Their Networks of Interlocked DNAon November 16, 2021 at 6:40 pm
By studying this amazing structure, how did scientists learn about RNA editing? The first tools developed for the study of cells and tissues were optical microscopes. These microscopes use visible ...
- Jonatha M. Gott, PhDon May 25, 2021 at 12:29 pm
My research focuses on RNA editing, the extraordinary process by which the primary sequence of specific RNAs are altered, leaving the genomic sequence unchanged. Such directed changes in RNA sequence ...
via Bing News